Brief: Arovella Therapeutics Says Europe Patent To Be Granted For Inkt Cell Therapy Platform
07/11/2022 24:57
Nov 7 (Reuters) - Arovella Therapeutics Ltd ALA.AX :
* EUROPE PATENT TO BE GRANTED FOR INKT CELL THERAPY PLATFORM
Source text for Eikon: ID:nASX9vQLNx
Further company coverage: ALA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO